RE:RE:RE:RE:Bad day for KNRBCdude, if that was the case I would have said something like this: "The commercialization and marketing for the BioCloud is in its early stages. At this time we can reasonably expect to achieve at least $10 million in sales this fiscal year and will provide a revised forecast later in the year as sales and marketing activities continue including onboarding of additional distributors." Is this is a fair reflection? If it is, why couldnt anybody looking at the draft newsrelease not predict what kind of a train wreck was being launched today? Did none of them do the math and figure 100 BC sales per month and compare to the max capacity they are aiming for and figure out whether they need a better description? But here we are, trying to read between the lines. Sorry KNR, big F on communication...either in the past or today or both. Must do better, and communication may be the easiest of all things. If the above is correct, fix it!
BCdude wrote: I agree with most of what you say, Canyousay, but I'm going to disagree with you on this one. Reading between the lines, Paul was probably waiting for something newsworthy to share and has been getting poked by investors to update the situation. He finally did today, and gave the numbers he's reasonably confident in achieving. I think that's what he had to do. I hate CEOs that are all sizzle and no steak. At the moment, this steak is more like ground beef, but I assume it's an honest assessment on actual sales he can see. Then, by setting the bar fairly low, the forecasts will either turn out to be accurate or shareholders can enjoy a happy surprise.
My two cents.
canyousayiii wrote: I agree with you. And if you are still onboarding diatributors and will likely continue, how do you prejudge their rate of success? I dont know. I know of forward looking disclaimers but they can't amount to a complete disregard of the forecast? Can they? If they can, why not pump it up? Everyone would be happier with a higher share price, no, and then give yourself a longer fighting chance for that bigger contract? Or just dont put out a forecast for the year going out 9 months but talk about the last 3 and what is to be shipped...which we all knew was not spectacular. We wanted something, but it has to be reasonably reliable or reasonably explained. Am I way off?
BCdude wrote: I agree. A conference call where Paul is forced to take questions from investors would be most welcome. Perhaps when the year-end financials are released? We'll see how transparent he is. History suggests he might not add much colour.
Regarding the guidance for 2021, he used the word "visibility" to sales of biocloud in the $10-11 million range. To me that seems like a carefully chosen word. My guess is that we can assume this is the floor for biocloud sales, with plenty of optionality to increase that. I wouldn't be surprised if Paul has no idea how much "interest" will evenutally convert into sales. As a former business owner, I was often surprised when certain sales I had been expecting didn't pan out, and some occasions when sales I didn't expect came out of left field.
canyousayiii wrote: The damage to the credibility will take more time to shake off than the realization of how poor the BioCloud demand is at this point. Folk keep hoping that it is early to make such a forecast and there will be some contracts that will blow this forecast. I would hope so too, except that would be a materially different picture than they painted today and unfortunately exceeding expectations they put out today would be problematic. So, how could they put out a forecast for the whole year so early? I don't know...but they did, without any wiggle room. I don't get it because I can see no upside to that wisdom but only downside. Downside if they materially come under that forecast, and downside if they materially exceed it. I am disappointed to reach my own conclusion that they are really not good at, at least, some important aspects of running a publicly traded company and that I cannot read anything into any future communication that may be cryptic or subject to multiple interpretations. KNR for me has turned from an investment to just another gamble. Thought they were different. Very disappointing. It would be nice if the CEO would organize a conference call and face the music with clear answers to what would be nothing but tough questions as a start to rebuilding any level of trust.